University of Michigan Rogel Cancer Center

University of Michigan Rogel Cancer Center Our mission is the conquest of cancer through innovation and collaboration.
(775)

The five-year survival rate has increased for all cancers, according to the American Cancer Society's latest report. Lea...
01/29/2026

The five-year survival rate has increased for all cancers, according to the American Cancer Society's latest report.

Learn more from Dr. Henry, who explains how healthy lifestyle choices, early screening and clinical trials have helped improve cancer survival rates: https://michmed.org/Q97Av.

One Day Closer to a Cure invites high school students to explore cancer research and careers through interactive activit...
01/24/2026

One Day Closer to a Cure invites high school students to explore cancer research and careers through interactive activities, engaging research talks, and lab tours. We hope this event inspires the next generation of scientists and clinicians, building a strong future in advancing cancer research and care. More info and registration: https://michmed.org/DQRbW

01/21/2026

Treating cancer is a team effort. Liver cancer is no exception. Through team discussions and patient evaluations, those with certain liver tumors have access to latest treatment options.

Gastroenterologist Neehar Parikh along with interventional radiologist Mishal Mendiratta-Lala discuss the latest treatment option for liver cancer – Histotripsy.

Histotripsy was created at the University of Michigan and has been approved by the FDA for use on liver tumors. While still relatively new, the dedicated clinic for patients who could benefit from Histotripsy, offers them a non-invasive approach with very good outcomes in order maintain their quality of life.

Join us for a live chat with gastroenterologist Neehar Parikh along with interventional radiologists, Mishal Mendiratta-...
01/21/2026

Join us for a live chat with gastroenterologist Neehar Parikh along with interventional radiologists, Mishal Mendiratta-Lala and Elaine Caoili discuss the latest treatment option for liver cancer – Histotripsy.

Histotripsy was created at the University of Michigan and has been approved by the FDA for use on liver tumors. While still relatively new, the dedicated clinic for patients who could benefit from Histotripsy, offers them a non-invasive approach with very good outcomes in order maintain their quality of life. 🔗https://www.youtube.com/live/ye5zy4rKBuM

Using machine learning, U-M researchers have created a "digital twin" of the brain, which can help map real-time tumor m...
01/20/2026

Using machine learning, U-M researchers have created a "digital twin" of the brain, which can help map real-time tumor metabolism in brain cancer patients.

This approach could help doctors discover which treatment strategies are most likely to be effective against individual cases of glioma. Learn more: https://michmed.org/JDm9A.

Although an estimated 10 million PSA tests are performed annually, there are few tools available to interpret the result...
01/16/2026

Although an estimated 10 million PSA tests are performed annually, there are few tools available to interpret the results and help patients decide what course of action to take.

U-M researchers have developed a model that can help patients understand their PSA results and what they mean for life expectancy.

Learn more: https://michmed.org/zgP4W.

Screening saves lives. As the new year begins, prioritize your preventive health by scheduling your regular screenings. ...
12/19/2025

Screening saves lives. As the new year begins, prioritize your preventive health by scheduling your regular screenings. 🗓

Have questions? Call our Cancer AnswerLine at 800-865-1125 or email: CancerAnswerLine@med.umich.edu

Glioblastoma is the most common and aggressive brain tumor in adults. One of the biggest challenges with treatment is th...
12/18/2025

Glioblastoma is the most common and aggressive brain tumor in adults. One of the biggest challenges with treatment is the blood-brain barrier, which makes it difficult to measure whether a treatment approach is working.

U-M researchers have developed a microfluidic device can be used to determine the effectiveness of chemotherapy drugs in patients with glioblastoma.

Learn more: https://michmed.org/dYQeq.

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lun...
12/17/2025

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States.

Over 80% of lung cancers are non-small cell lung cancers. Many gene mutations are associated with non-small cell lung cancer, including the gene KRAS, which is important for cell growth and division and is mutated in 30% of cases.

University of Michigan researchers found a new protein target and developed a drug to treat non-small cell lung cancers that have KRAS mutations.

Learn more: https://michmed.org/eQ595.

Address

1500 E Medical Center Drive
Ann Arbor, MI
48109

Telephone

+18008651125

Website

Alerts

Be the first to know and let us send you an email when University of Michigan Rogel Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category